Literature DB >> 12112219

Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis.

Steven Frucht1.   

Abstract

Rasmussen's encephalitis is a rare autoimmune disorder characterized by intractable epilepsy and progressive hemispheric dysfunction. The disorder usually affects children, although cases have been reported with symptom onset in late adolescence or adulthood. Myoclonus is common in Rasmussen patients, usually occurring as part of epilepsia partialis continua (EPC); however, other hyperkinetic movements are rare. This report documents a 19-year-old woman with Rasmussen's encephalitis whose clinical presentation was dominated by foot dystonia, arm athetosis, and EPC. Intravenous immunoglobulin improved both hyperkinetic movements and EPC, but benefit was transient. The clinical significance and implications of these findings are discussed. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112219     DOI: 10.1002/mds.10131

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

Review 1.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 2.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

3.  Hemichorea in Rasmussen's Encephalitis-A Rare Case.

Authors:  Abu Tahir Shaikh; Animesh Das; Ajay Garg; Divya M Radhakrishnan; Awadh Kishor Pandit; Ayush Agarwal; Achal Kumar Srivastava
Journal:  Mov Disord Clin Pract       Date:  2022-04-11

4.  Triple Pathology in Rasmussen's Encephalitis: A New Pathological Phenotype.

Authors:  Ayush M Makkar; Snigdha Komakula; Ayush Agarwal; Saumya Sahu; Vaishali Suri; Achal K Srivasatava
Journal:  Ann Indian Acad Neurol       Date:  2022-02-14       Impact factor: 1.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.